William D Martin

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Venues

Expert review of vaccines

Influenza and other respiratory viruses

Human vaccines & immunotherapeutics

EpiVax (United States)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

EpiVax (United States)

United States

CIO

Publications

Guilhem Richard, Nicole Ruggiero, Gary D Steinberg, William D Martin, Anne Searls De Groot
Neoadjuvant personalized cancer vaccines: the final frontier? Expert review of vaccines 23 (1) (2024)
Guilhem Richard, Nicole Ruggiero, Gary D Steinberg, William D Martin, Anne Searls De Groot
Neoadjuvant personalized cancer vaccines: the final frontier? Expert review of vaccines (2024)
Guilhem Richard, Nicole Ruggiero, Gary D Steinberg, William D Martin, Anne Searls De Groot
Neoadjuvant personalized cancer vaccines: the final frontier? Expert review of vaccines 23 (1) (2024)
Guilhem Richard, Nicole Ruggiero, Gary D Steinberg, William D Martin, Anne Searls De Groot
Neoadjuvant personalized cancer vaccines: the final frontier? Expert review of vaccines 23 (1) (2024)
Leonard Moise, Ted M Ross, Daniel F Hoft, William D Martin, Anne Searls De Groot
Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines. Expert review of vaccines 19 (9) (2020)
Sundos Khan, Matthew Parrillo, Andres Hazaet Gutiérrez, Frances E Terry, Leonard Moise, William D Martin, Anne Searls De Groot
Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi. Human vaccines & immunotherapeutics 16 (2) (2019)
Andres Hazaet Gutiérrez, Vicki J Rapp-Gabrielson, Frances E Terry, Crystal L Loving, Leonard Moise, William D Martin, Anne Searls De Groot
T-cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin. Influenza and other respiratory viruses 11 (6) (2018)

William D Martin

Publication Activity (10 Years)

Top Topics

Top Venues